Free Delivery Over $100
|
|
|||
|
||||
OverviewThe availability of new molecular approaches to the selection of drug therapy is an emerging need, as the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many, and in most cases the majority of treated patients do not have significant benefits from the treatment while they often experience moderate to severe toxicities. In Pharmacogenomics, Anticancer Drug Discovery, and Response, edited by Federico Innocenti, readers will find a series of chapters addressing the role of genomic information in cancer therapy and in drug development representing a unique source, as it describes experimental approaches, statistical strategies, and clinical examples of the application of genomic medicine in oncology. This book provides the most comprehensive body of knowledge on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. Full Product DetailsAuthor: Federico InnocentiPublisher: Springer Imprint: Springer Dimensions: Width: 28.00cm , Height: 2.10cm , Length: 21.00cm Weight: 0.889kg ISBN: 9781603279734ISBN 10: 1603279733 Pages: 396 Publication Date: 23 February 2009 Audience: General/trade , General Format: Undefined Publisher's Status: Unknown Availability: Out of stock  Table of ContentsReviews<p>From the reviews: <p> The chapters of this book, written by outstanding scientists in the field of cancer pharmacogenomics, clearly show how DNA information from both the host and the tumor should be taken into account for rational selection of drug therapies in cancer patients. the book provides a comprehensive and in-depth view of the field of cancer pharmacogenomics. The book is informative for clinicians, for people involved in development of cancer therapeutics on industrial level, and any scientists who are interested in cancer biology. (C. Altaner, Neoplasma, June, 2009)<p> The chapters of this book, written by outstanding scientists in the field of cancer pharmacogenomics . the book provides a comprehensive and in-depth view of the field of cancer pharmacogenomics. The book is informative for clinicians, for people involved in development of cancer therapeutics on industrial level, and any scientists who are interested in cancer biology. (C. Altaner, Neoplasma, April, 2 Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
